{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T16:53:21Z","timestamp":1755795201837,"version":"3.44.0"},"reference-count":8,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Open Heart"],"accepted":{"date-parts":[[2017,11,17]]},"published-print":{"date-parts":[[2018,1]]},"abstract":"<jats:p>Transcatheter aortic valve replacement (TAVR) has become the preferred therapy for treatment of severe aortic stenosis in patients at intermediate to high risk of perioperative mortality following surgical aortic valve replacement. Haemodynamic assessment is an integral part of the procedure, and it is crucial for the operator to have an in-depth understanding of the haemodynamic alterations that occur during balloon aortic valvuloplasty and transcatheter valve deployment. Comprehension of the haemodynamic tracings is also pivotal for early recognition of periprocedural complications. With expanding indications for TAVR, it is imperative for members of the structural heart team to have an in-depth, nuanced understanding of transcatheter haemodynamic waveforms and their correlation with echocardiographic Doppler waveforms that are obtained periprocedurally during TAVR. This review provides a collection of transcatheter haemodynamic tracings and their corresponding Doppler echocardiography correlates that are demonstrative of physiological alterations and pathological lesions (complications) that occur during TAVR.<\/jats:p>","DOI":"10.1136\/openhrt-2017-000728","type":"journal-article","created":{"date-parts":[[2018,1,12]],"date-time":"2018-01-12T20:10:42Z","timestamp":1515787842000},"page":"e000728","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Transcatheter and Doppler waveform correlation in transcatheter aortic valve replacement"],"prefix":"10.1136","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0080-1660","authenticated-orcid":false,"given":"Ankur","family":"Kalra","sequence":"first","affiliation":[{"name":"Harrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raj R","family":"Makkar","sequence":"additional","affiliation":[{"name":"Cedars-Sinai Heart Institute, Los Angeles, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepak L","family":"Bhatt","sequence":"additional","affiliation":[{"name":"Brigham and Women\u2019s Heart and Vascular Center, Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sahil","family":"Khera","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neal S","family":"Kleiman","sequence":"additional","affiliation":[{"name":"Houston Methodist DeBakey Heart and Vascular Center, Houston Methodist Hospital, Houston, Texas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J","family":"Reardon","sequence":"additional","affiliation":[{"name":"Houston Methodist DeBakey Heart and Vascular Center, Houston Methodist Hospital, Houston, Texas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morton J","family":"Kern","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Veterans Affairs Long Beach Healthcare System, Long Beach, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2018,1,11]]},"reference":[{"key":"2025081710553041000_5.1.e000728.1","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1056\/NEJMe1603473","article-title":"Will tavr become the predominant method for treating severe aortic stenosis?","volume":"374","author":"Moat","year":"2016","journal-title":"N Engl J Med"},{"doi-asserted-by":"publisher","key":"2025081710553041000_5.1.e000728.2","DOI":"10.1016\/j.jacc.2016.11.033"},{"doi-asserted-by":"publisher","key":"2025081710553041000_5.1.e000728.3","DOI":"10.1016\/S0735-1097(02)02764-X"},{"doi-asserted-by":"publisher","key":"2025081710553041000_5.1.e000728.4","DOI":"10.1093\/eurheartj\/ehv574"},{"doi-asserted-by":"publisher","key":"2025081710553041000_5.1.e000728.5","DOI":"10.1016\/j.jcin.2012.04.011"},{"doi-asserted-by":"publisher","key":"2025081710553041000_5.1.e000728.6","DOI":"10.1016\/j.jacc.2011.11.048"},{"doi-asserted-by":"publisher","key":"2025081710553041000_5.1.e000728.7","DOI":"10.1161\/CIRCULATIONAHA.113.002947"},{"key":"2025081710553041000_5.1.e000728.8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11936-016-0440-3","article-title":"Evaluation and management of concomitant hypertrophic obstructive cardiomyopathy and valvular aortic stenosis","volume":"18","author":"Shenouda","year":"2016","journal-title":"Curr Treat Options Cardiovasc Med"}],"container-title":["Open Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/openhrt-2017-000728","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T17:55:41Z","timestamp":1755453341000},"score":1,"resource":{"primary":{"URL":"https:\/\/openheart.bmj.com\/lookup\/doi\/10.1136\/openhrt-2017-000728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":8,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,1,11]]},"published-print":{"date-parts":[[2018,1]]}},"alternative-id":["10.1136\/openhrt-2017-000728"],"URL":"https:\/\/doi.org\/10.1136\/openhrt-2017-000728","relation":{},"ISSN":["2053-3624"],"issn-type":[{"type":"electronic","value":"2053-3624"}],"subject":[],"published":{"date-parts":[[2018,1]]}}}